Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Trump

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 19, 2025
Navigating the precipice: Lessons on collapse from the Late Bronze AgeS E Galaitsi, Benjamin D Trump, Eric H Cline, et al.
The New England Journal of Medicine|December 10, 1999
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancerE M Messing, J Manola, M Sarosdy, et al.
The British Journal of Ophthalmology|December 20, 2005
Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisationT Wang, A Zhou, C T Waters, et al.
Journal of Medical Genetics|May 18, 2010
SMARCB1 mutations are not a common cause of multiple meningiomasK D Hadfield, M J Smith, D Trump, et al.
Environment Systems & Decisions|August 23, 2022
Defining and analyzing health system resilience in rural jurisdictionsMason Barnard, Sienna Mark, Scott L Greer, et al.
International Journal of Information Management|April 7, 2021
The challenges of data usage for the United States' COVID-19 responseS E Galaitsi, Jeffrey C Cegan, Kaitlin Volk, et al.
Human Genetics|July 8, 1999
Exclusion of RAI2 as the causative gene for Nance-Horan syndromeS M Walpole, N Ronce, C Grayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot studyJ Grem, P O'Dwyer, P Elson, et al.
Clinical Endocrinology|August 1, 1996
Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumoursS H Pearce, D Trump, C Wooding, et al.
Frontiers in Bioengineering and Biotechnology|September 15, 2023
The worsening divergence of biotechnology: the importance of risk cultureBenjamin D Trump, Christopher L Cummings, Nicholas Loschin, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 19, 2025
Navigating the precipice: Lessons on collapse from the Late Bronze AgeS E Galaitsi, Benjamin D Trump, Eric H Cline, et al.
The New England Journal of Medicine|December 10, 1999
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancerE M Messing, J Manola, M Sarosdy, et al.
The British Journal of Ophthalmology|December 20, 2005
Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisationT Wang, A Zhou, C T Waters, et al.
Journal of Medical Genetics|May 18, 2010
SMARCB1 mutations are not a common cause of multiple meningiomasK D Hadfield, M J Smith, D Trump, et al.
Environment Systems & Decisions|August 23, 2022
Defining and analyzing health system resilience in rural jurisdictionsMason Barnard, Sienna Mark, Scott L Greer, et al.
International Journal of Information Management|April 7, 2021
The challenges of data usage for the United States' COVID-19 responseS E Galaitsi, Jeffrey C Cegan, Kaitlin Volk, et al.
Human Genetics|July 8, 1999
Exclusion of RAI2 as the causative gene for Nance-Horan syndromeS M Walpole, N Ronce, C Grayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot studyJ Grem, P O'Dwyer, P Elson, et al.
Clinical Endocrinology|August 1, 1996
Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumoursS H Pearce, D Trump, C Wooding, et al.
Frontiers in Bioengineering and Biotechnology|September 15, 2023
The worsening divergence of biotechnology: the importance of risk cultureBenjamin D Trump, Christopher L Cummings, Nicholas Loschin, et al.
Pageof 8